If you’re building a biotech or life science SME, let’s talk about how to turn complexity into clarity—and strategy into growth.

A few months ago, I attended a local biotech industry event and reconnected with a former client. I had witnessed their journey from the early days—scrappy, ambitious, resource-constrained—to a more mature organization that had recently been acquired. The transformation was significant: new structure, new priorities, new internal dynamics.

Growth brings change. That’s expected.

What surprised me wasn’t the multitasking culture. I’ve worked with SMEs across biotech and life sciences long enough to know that when resources are tight, everyone wears multiple hats.

What caught my attention was something else: the person leading purchasing was also responsible for marketing.

In a highly specialized, science-driven industry, this raises a serious question.

Who is shaping the message?

Biotech and life science companies operate in complex, technical markets. Their audiences—scientists, clinicians, procurement teams, investors—expect precision, clarity, and credibility. Crafting that message requires more than good intentions. It requires scientific understanding, market insight, and strategic positioning.

As organizations evolve, their cost structures evolve too. In early-stage startups, investment naturally flows into R&D. Sales and marketing can wait—until the product is ready to meet the market.

But when that moment comes, communication is no longer optional. It becomes strategic.

And strategy cannot be improvised.

Would you entrust the launch of your innovative, hard-earned portfolio to someone without deep scientific context or a clear understanding of your customer?

Defining roles, responsibilities, hierarchy, communication flows, procedures, and culture isn’t bureaucracy—it’s strategy. For biotech and life science SMEs, how you structure marketing, product management, and communication can determine whether your innovation is understood… or overlooked.

In this industry, being scientifically brilliant is not enough. You must also be strategically visible.

So I’ll leave you with one question:

Where do you want your company to stand in the market—and who is leading the conversation to get you there? 

Visibility is not the goal. 

Impact is. 

LinkedIn Post

#biotech #lifesciences #biotechstartup #biotechmarketing #lifesciencesmarketing #biotechcommunication #marketingstrategy #brandpositioning #b2bmarketing #europeanbiotech #biotechmarketingstrategy #biotechbrandpositioning #complexsciencecommunication #biotechdigitalmarketing #communicationforbiotech #biotechmessaging